NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Curebase

Curebase

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.curebase.ai/

Last Round

Series B

May 5, 2022

Est. Valuation

$1.71M

Total Funding Raised

$73.97M

Company Overview

Curebase is a healthcare technology company that provides an AI-powered eClinical software platform for decentralized clinical trials, streamlining participant eligibility, enrollment, education, and consent processes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

decentralized clinical trialsDCTclinical trial softwareeClinical platformhybrid clinical trialsvirtual clinical trialselectronic data captureEDCeConsentCRO servicescontract research organizationCROelectronic patient-reported outcomesePROpatient recruitmentclinical trial management systemCTMSdigital therapeutics trialsclinical operations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curebase Comparables

Compare Curebase with similar companies based on industry and business-model similarity.

Curebase comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
THREAD
89%
Obvio Health
89%
Vial
86%

Curebase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 5, 2022
Series AMay 25, 2021
Series AApr 22, 2021
SeedOct 1, 2018
AcceleratorAug 22, 2018

Key People

Founding team and executive leadership

Storm Stillman

Chief Executive Officer, Board Member

Executive Team

Tom Lemberg

Founder CEO

Founding Team

Scott Garcia

Chief Financial Officer

Executive Team

Curebase Investors

Notable investors and investment history

Curebase investors
InvestorRounds
World Innovation LabSeries B
GaingelsSeries B
Positive SumSeries B
Acrew CapitalSeries B
FJ LabsSeed
BOLD Capital PartnersSeries A, Series B
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2022

    $40M round led by Industry Ventures.

  • May 25, 2021

    $15M round led by GGV Capital.

Curebase Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Curebase Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Curebase's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range57
Year Founded2017
Last FundingMay 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.